MarketBeat Instant News Alerts 2 hours agoChardan Capital Initiates Coverage on MannKind (NASDAQ:MNKD)MarketBeatChardan Capital initiated coverage on shares of MannKind in a report on Monday. They set a "buy" rating and a $10.00 price objective on the stock.NASDAQ:MNKDRead Chardan Capital Initiates Coverage on MannKind (NASDAQ:MNKD)2 hours agoMizuho Issues Pessimistic Forecast for NETSTREIT (NYSE:NTST) Stock PriceMarketBeatMizuho lowered their price objective on NETSTREIT from $20.00 to $19.00 and set an "outperform" rating for the company in a research report on Monday.NYSE:NTSTRead Mizuho Issues Pessimistic Forecast for NETSTREIT (NYSE:NTST) Stock Price2 hours agoRealty Income (NYSE:O) Given New $59.00 Price Target at MizuhoMarketBeatMizuho dropped their price objective on Realty Income from $61.00 to $59.00 and set a "neutral" rating for the company in a research note on Monday.NYSE:ORead Realty Income (NYSE:O) Given New $59.00 Price Target at Mizuho2 hours agoWix.com (NASDAQ:WIX) Given New $90.00 Price Target at Cantor FitzgeraldMarketBeatCantor Fitzgerald increased their price objective on shares of Wix.com from $80.00 to $90.00 and gave the stock an "overweight" rating in a research report on Monday.NASDAQ:WIXRead Wix.com (NASDAQ:WIX) Given New $90.00 Price Target at Cantor Fitzgerald2 hours agoZentalis Pharmaceuticals (NASDAQ:ZNTL) Stock Keeps "Buy" Rating at HC WainwrightMarketBeatHC Wainwright restated a "buy" rating and issued a $10.00 price target on shares of Zentalis Pharmaceuticals in a research report on Monday.NASDAQ:ZNTLRead Zentalis Pharmaceuticals (NASDAQ:ZNTL) Stock Keeps "Buy" Rating at HC Wainwright2 hours agoCleveland-Cliffs (NYSE:CLF) Announces Quarterly Earnings Results, Beats Estimates By $0.07 EPSMarketBeatCleveland-Cliffs (NYSE:CLF - Get Free Report) announced its quarterly earnings results on Monday. The mining company reported $0.28 EPS for the quarter, beating analysts' consensus estimates of $0.21 by $0.07. Cleveland-Cliffs had a negative return on equity of 13.37% and a negative net margin of 4.56%. The company had revenue of $5.61 billion during the quarter, compared to analysts' expectations of $5.69 billion. During the same period in the prior year, the company earned ($0.51) EPS. NYSE:CLFRead Cleveland-Cliffs (NYSE:CLF) Announces Quarterly Earnings Results, Beats Estimates By $0.07 EPS Trending News1Advanced Micro Devices (NASDAQ:AMD) Stock Falls 5.7% - Here's Why2Fannie Mae (OTCMKTS:FNMA) Stock Jumps 13.3% - Here's What Happened3Amazon.com (NASDAQ:AMZN) Stock Falls 1.7% - Here's What Happened4Rolls-Royce Holdings PLC (OTCMKTS:RYCEY) Shares Shorted: Short Interest Down 41.4% in September5Walmart (NASDAQ:WMT) Shares Climb 3.5% - Here's What Happened6Plug Power (NASDAQ:PLUG) Upgraded to Sell at Wall Street Zen7IREN (NASDAQ:IREN) Stock Falls 12.2% - Time to Sell?8IREN (NASDAQ:IREN) Shares Gap Down - Should You Sell? All MarketBeat Instant News Alerts Latest News Trending News Sort By Last 24 Hours Last 3 Days Last 5 Days Last 7 Days Last 14 Days Last 30 Days Last 90 Days All Time Time Frame All Alerts Analyst Congressional Trades Consensus Corporate Buyback Corporate Event Transcript Dividend Earnings Earnings Preview Earnings Transcript Highlights Estimates Guidance Insider Trade Lockup Expiration MarketBeat List Articles Options Price SEC Filing Stock List Stock Split Alert Type Keywords More filters Fewer filters Done 2 hours agoTripAdvisor (NASDAQ:TRIP) Stock Price Target Lowered at Cantor FitzgeraldMarketBeatNASDAQ:TRIPRead TripAdvisor (NASDAQ:TRIP) Stock Price Target Lowered at Cantor Fitzgerald2 hours agoSol-Gel Technologies (NASDAQ:SLGL) Earns "Buy" Rating from HC WainwrightMarketBeatNASDAQ:SLGLRead Sol-Gel Technologies (NASDAQ:SLGL) Earns "Buy" Rating from HC Wainwright2 hours agoRecursion Pharmaceuticals (NASDAQ:RXRX) Given Buy Rating at Needham & Company LLCMarketBeatNASDAQ:RXRXRead Recursion Pharmaceuticals (NASDAQ:RXRX) Given Buy Rating at Needham & Company LLC2 hours agoQuantum Computing (NASDAQ:QUBT) Stock Keeps Buy Rating at Rosenblatt SecuritiesMarketBeatNASDAQ:QUBTRead Quantum Computing (NASDAQ:QUBT) Stock Keeps Buy Rating at Rosenblatt Securities2 hours agoOruka Therapeutics' (ORKA) "Buy" Rating Reaffirmed at BTIG ResearchMarketBeatNASDAQ:ORKARead Oruka Therapeutics' (ORKA) "Buy" Rating Reaffirmed at BTIG Research2 hours agoKeefe, Bruyette & Woods Issues Pessimistic Forecast for Northrim BanCorp (NASDAQ:NRIM) Stock PriceMarketBeatNASDAQ:NRIMRead Keefe, Bruyette & Woods Issues Pessimistic Forecast for Northrim BanCorp (NASDAQ:NRIM) Stock Price2 hours agoNewmark Group (NASDAQ:NMRK) Stock Keeps Neutral Rating at Piper SandlerMarketBeatNASDAQ:NMRKRead Newmark Group (NASDAQ:NMRK) Stock Keeps Neutral Rating at Piper Sandler2 hours agoMicrosoft (NASDAQ:MSFT) Stock Price Expected to Rise, Sanford C. Bernstein Analyst SaysMarketBeatNASDAQ:MSFTRead Microsoft (NASDAQ:MSFT) Stock Price Expected to Rise, Sanford C. Bernstein Analyst Says2 hours agoLyft (NASDAQ:LYFT) Given New $15.00 Price Target at Cantor FitzgeraldMarketBeatNASDAQ:LYFTRead Lyft (NASDAQ:LYFT) Given New $15.00 Price Target at Cantor Fitzgerald2 hours agoLiftoff Mobile (NASDAQ:LFTO) Stock Gets Price Target Trim from Cantor FitzgeraldMarketBeatNASDAQ:LFTORead Liftoff Mobile (NASDAQ:LFTO) Stock Gets Price Target Trim from Cantor Fitzgerald2 hours agoIntel (NASDAQ:INTC) Stock Moved Up to "Neutral" by JPMorgan Chase & Co.MarketBeatNASDAQ:INTCRead Intel (NASDAQ:INTC) Stock Moved Up to "Neutral" by JPMorgan Chase & Co.2 hours agoHarmony Biosciences' (HRMY) Buy Rating Reaffirmed at Needham & Company LLCMarketBeatNASDAQ:HRMYRead Harmony Biosciences' (HRMY) Buy Rating Reaffirmed at Needham & Company LLC2 hours agoHIVE Digital Technologies' (HIVE) Buy Rating Reaffirmed at Canaccord Genuity GroupMarketBeatNASDAQ:HIVERead HIVE Digital Technologies' (HIVE) Buy Rating Reaffirmed at Canaccord Genuity Group2 hours agoEnliven Therapeutics (NASDAQ:ELVN) Stock Price Expected to Rise, HC Wainwright Analyst SaysMarketBeatNASDAQ:ELVNRead Enliven Therapeutics (NASDAQ:ELVN) Stock Price Expected to Rise, HC Wainwright Analyst Says2 hours agoCoreWeave (NASDAQ:CRWV) Upgraded at The Goldman Sachs GroupMarketBeatNASDAQ:CRWVRead CoreWeave (NASDAQ:CRWV) Upgraded at The Goldman Sachs Group2 hours agoComcast (NASDAQ:CMCSA) Given Buy Rating at Rosenblatt SecuritiesMarketBeatNASDAQ:CMCSARead Comcast (NASDAQ:CMCSA) Given Buy Rating at Rosenblatt Securities2 hours agoCrescent Biopharma (NASDAQ:CBIO) Earns "Buy" Rating from HC WainwrightMarketBeatNASDAQ:CBIORead Crescent Biopharma (NASDAQ:CBIO) Earns "Buy" Rating from HC Wainwright2 hours agoBTIG Research Reaffirms Buy Rating for Bicara Therapeutics (NASDAQ:BCAX)MarketBeatNASDAQ:BCAXRead BTIG Research Reaffirms Buy Rating for Bicara Therapeutics (NASDAQ:BCAX)2 hours agoAdagene (NASDAQ:ADAG) Given "Buy" Rating at HC WainwrightMarketBeatNASDAQ:ADAGRead Adagene (NASDAQ:ADAG) Given "Buy" Rating at HC Wainwright2 hours agoACADIA Pharmaceuticals (NASDAQ:ACAD) Stock Keeps Buy Rating at Needham & Company LLCMarketBeatNASDAQ:ACADRead ACADIA Pharmaceuticals (NASDAQ:ACAD) Stock Keeps Buy Rating at Needham & Company LLC2 hours agoAardvark Therapeutics (NASDAQ:AARD) Stock Price Target Lowered at HC WainwrightMarketBeatNASDAQ:AARDRead Aardvark Therapeutics (NASDAQ:AARD) Stock Price Target Lowered at HC Wainwright2 hours agoKeefe, Bruyette & Woods Issues Pessimistic Forecast for Truist Financial (NYSE:TFC) Stock PriceMarketBeatNYSE:TFCRead Keefe, Bruyette & Woods Issues Pessimistic Forecast for Truist Financial (NYSE:TFC) Stock Price2 hours agoRollins (NYSE:ROL) Given New $35.00 Price Target at Sanford C. BernsteinMarketBeatNYSE:ROLRead Rollins (NYSE:ROL) Given New $35.00 Price Target at Sanford C. Bernstein2 hours agoRegions Financial (NYSE:RF) Raised to "Buy" at Brean CapitalMarketBeatNYSE:RFRead Regions Financial (NYSE:RF) Raised to "Buy" at Brean Capital Featured Articles and OffersSalesforce Just Got a Rare Double Upgrade—What Changed?By Jeffrey Neal Johnson | October 12, 2026Your book attachedFrom Profits Run (Ad)These 3 Green Stocks Have a Growth Story That Goes Far Beyond WashingtonBy Chris Markoch | October 18, 2026Tesla Wants to Make Its Own Chips—What Could Go Wrong?By Sam Quirke | October 14, 2026A Chinese Rival Just Spooked Memory Stocks—How Worried Should Micron Investors Be?By Jeffrey Neal Johnson | October 13, 2026He turned $12K into $1.65M without touching Apple or TeslaFrom Tim Sykes (Ad)ASML Can’t Keep Up With AI Demand—Why That's a Good ThingBy Thomas Hughes | October 15, 2026IonQ Fell 9% on a $1.3 Billion Deal—Is Wall Street Missing Something?By Jeffrey Neal Johnson | October 13, 2026 Alert CategoriesAll AlertsAnalystCongressional TradesConsensusCorporate BuybackCorporate Event TranscriptStock ListDividendEarningsEarnings PreviewEarnings Transcript HighlightsEstimatesGuidanceInsider TradeLockup ExpirationMarketBeat List ArticlesOptionsPriceSEC FilingStock Split Page 1 of 282 1234567 Earlier › Earliest » Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
